Clinical trial NCT00798876 - References

Prostate Cancer — Low-Fat Fish Oil Diet for Prostate Cancer Prevention

Citation(s)

•   Ablin RJ, Shaw MW
  Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res. 1986 Mar-Apr;6(2):327-8.
•   Bagga D, Capone S, Wang HJ, Heber D, Lill M, Chap L, Glaspy JA
  Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst. 1997 Aug 6;89(15):1123-31.
•   Baghurst KI, Crawford DA, Worsley A, Record SJ
  The Victorian Nutrition Survey--intakes and sources of dietary fats and cholesterol in the Victorian population. Med J Aust. 1988 Jul 4;149(1):12-5, 18-20.
•   Boyle P, Levi F, Lucchini F, La Vecchia C, Kevi R [corrected to Levi F], Lucchuni F [corrected to Lucchini F]
  Trends in diet-related cancers in Japan: a conundrum? Lancet. 1993 Sep 18;342(8873):752. Erratum in: Lancet 1993 Oct 16;342(8877):1000.
•   Bucher C, Jordan P, Nickeleit V, Torhorst J, Mihatsch MJ
  Relative risk of malignant tumors in analgesic abusers. Effects of long-term intake of aspirin. Clin Nephrol. 1999 Feb;51(2):67-72.
•   Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M
  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23;279(5350):563-6.
•   Cook LS, Goldoft M, Schwartz SM, Weiss NS
  Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol. 1999 Jan;161(1):152-5.
•   Culp BR, Titus BG, Lands WE
  Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med. 1979 Nov;3(5):269-78.
•   Donaghy AJ, Baxter RC
  Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. Baillieres Clin Endocrinol Metab. 1996 Jul;10(3):421-46. Review.
•   Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC
  Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 1997 Nov 1;57(21):4667-72.
•   Feldman JM, Hilf R
  A role of estrogens and insulin binding in the dietary lipid alteration of R3230AC mammary carcinoma growth in rats. Cancer Res. 1985 May;45(5):1964-72.
•   Ferry RJ Jr, Katz LE, Grimberg A, Cohen P, Weinzimer SA
  Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res. 1999 Feb-Mar;31(2-3):192-202. Review.
•   Fradet Y, Meyer F, Bairati I, Shadmani R, Moore L
  Dietary fat and prostate cancer progression and survival. Eur Urol. 1999;35(5-6):388-91. Review.
•   Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CG, Willett WC
  A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9. Erratum in: J Natl Cancer Inst. 2013 Jul 3;105(13):944. Chute, C C [corrected to Chute, C G].
•   Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, Sandler RS
  Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):889-95.
•   Grimberg A, Cohen P
  Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000 Apr;183(1):1-9. Review.
•   Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H
  Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate. 2000 Jan;42(1):73-8.
•   Hansen HS
  Dietary essential fatty acids and in vivo prostaglandin production in mammals. World Rev Nutr Diet. 1983;42:102-34. Review.
•   Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, Chien HT, Blot WJ
  Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990 Nov 1;50(21):6836-40.
•   Hwang D, Scollard D, Byrne J, Levine E
  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998 Mar 18;90(6):455-60.
•   Iwamura M, Sluss PM, Casamento JB, Cockett AT
  Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate. 1993;22(3):243-52.
•   Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM
  The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res. 1999 May 1;59(9):2203-9.
•   Karmali RA
  Eicosanoids in neoplasia. Prev Med. 1987 Jul;16(4):493-502.
•   Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu XH, Levine AC
  Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology. 2000 Oct 1;56(4):671-6.
•   Kobayashi M, Sasaki S, Hamada GS, Tsugane S
  Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese populations in Japan and Brazil. Jpn J Cancer Res. 1999 Sep;90(9):914-21.
•   Kolonel LN, Yoshizawa CN, Hankin JH
  Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol. 1988 May;127(5):999-1012.
•   Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD
  Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000 Jan;71(1 Suppl):179S-88S. doi: 10.1093/ajcn/71.1.179S. Review.
•   Landis SH, Murray T, Bolden S, Wingo PA
  Cancer statistics, 1999. CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1.
•   Lepage G, Roy CC
  Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986 Jan;27(1):114-20.
•   Levy GN
  Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 1997 Mar;11(4):234-47. Review.
•   Magoha GA
  Ten years experience with chronic prostatitis in Africans. East Afr Med J. 1996 Mar;73(3):176-8.
•   Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO
  Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer. 1997;76(9):1115-8.
•   Marnett LJ
  Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates. Environ Health Perspect. 1990 Aug;88:5-12. Review.
•   Mishina T, Watanabe H, Araki H, Nakao M
  Epidemiological study of prostatic cancer by matched-pair analysis. Prostate. 1985;6(4):423-36.
•   Muir CS, Nectoux J, Staszewski J
  The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol. 1991;30(2):133-40. Review.
•   Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK
  Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst. 1999 Mar 17;91(6):512-23.
•   Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB
  Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997 May;21(5):355-9.
•   Norrish AE, Jackson RT, McRae CU
  Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer. 1998 Aug 12;77(4):511-5.
•   Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ, Jackson RT
  Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer. 1999 Dec;81(7):1238-42.
•   Nyomba BL, Berard L, Murphy LJ
  Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab. 1997 Jul;82(7):2177-81.
•   Pandalai PK, Pilat MJ, Yamazaki K, Naik H, Pienta KJ
  The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res. 1996 Mar-Apr;16(2):815-20.
•   Parkin DM, Pisani P, Ferlay J
  Global cancer statistics. CA Cancer J Clin. 1999 Jan-Feb;49(1):33-64, 1.
•   Rose DP, Cohen LA
  Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis. 1988 Apr;9(4):603-5.
•   Rose DP, Connolly JM
  Dietary fat, fatty acids and prostate cancer. Lipids. 1992 Oct;27(10):798-803. Review.
•   Rose DP, Connolly JM
  Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate. 1991;18(3):243-54.
•   Rubenstein M, Shaw MW, McKiel CF, Ray PS, Guinan PD
  Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants. Cancer Res. 1987 Jan 1;47(1):178-82.
•   Scacchi M, Pincelli AI, Cavagnini F
  Growth hormone in obesity. Int J Obes Relat Metab Disord. 1999 Mar;23(3):260-71. Review.
•   Schuman LM, Mandel JS, Radke A, et al: Some elected features of the epidemiology of prostatic cancer: Minneapolis-St
  Paul, Minnesota case-control study, 1976-1979. In: Magnus K, ed. Trends in cancer incidence. Washington DC: Hemisphere, 345-354, 1982.
•   Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA
  Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer. 1999 Sep 15;86(6):1019-27.
•   Severson RK, Nomura AM, Grove JS, Stemmermann GN
  A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989 Apr 1;49(7):1857-60.
•   Shaw MW, Ablin RJ, Ray P, Rubenstein M, Guinan PD, McKiel CF
  Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol. 1985 Jul;8(3):77-9.
•   Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM
  Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991 Jun;63(6):963-6.
•   Shin BC, Ebner KE, Hudson BG, Carraway KL
  Membrane glycoprotein differences between normal lactating mammary tissue and the R3230 AC mammary tumor. Cancer Res. 1975 May;35(5):1135-40.
•   Signorello LB, Brismar K, Bergstrom R, Andersson SO, Wolk A, Trichopoulos D, Adami HO
  Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst. 1999 Nov 17;91(22):1965-7.
•   Smith BJ, Wills MR, Savory J
  Prostaglandins and cancer. Ann Clin Lab Sci. 1983 Sep-Oct;13(5):359-65. Review.
•   Stellman SD, Wang QS
  Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer. 1994 Feb 15;73(4):1270-5.
•   Sugano M, Hirahara F
  Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr. 2000 Jan;71(1 Suppl):189S-96S. doi: 10.1093/ajcn/71.1.189S. Review.
•   Thissen JP, Ketelslegers JM, Underwood LE
  Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994 Feb;15(1):80-101. Review.
•   Tjandrawinata RR, Dahiya R, Hughes-Fulford M
  Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer. 1997;75(8):1111-8.
•   Tsujii M, Kawano S, DuBois RN
  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3336-40.
•   Vane JR, Bakhle YS, Botting RM
  Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120. Review.
•   Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD
  Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 1995 Oct 4;87(19):1456-62.
•   West DW, Slattery ML, Robison LM, French TK, Mahoney AW
  Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991 Mar;2(2):85-94.
•   Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et al
  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995 May 3;87(9):652-61.
•   Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D
  Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst. 1998 Jun 17;90(12):911-5.
•   Wynder EL, Fujita Y, Harris RE, Hirayama T, Hiyama T
  Comparative epidemiology of cancer between the United States and Japan. A second look. Cancer. 1991 Feb 1;67(3):746-63.
•   Yatani R, Kusano I, Shiraishi T, Hayashi T, Stemmermann GN
  Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn J Clin Oncol. 1989 Dec;19(4):319-26. Review.
•   Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, Wada S
  Expression of cyclooxygenase-2 in prostate carcinoma. Cancer. 2000 Aug 1;89(3):589-96.
•   Yu H, Rohan T
  Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000 Sep 20;92(18):1472-89. Review.
•   Zhou JR, Blackburn GL
  Bridging animal and human studies: what are the missing segments in dietary fat and prostate cancer? Am J Clin Nutr. 1997 Dec;66(6 Suppl):1572S-1580S. doi: 10.1093/ajcn/66.6.1572S. Review.

Comparison Study of a Low-Fat Diet Supplemented With Fish Oil and a Standard Western Diet in Individuals With Prostate Cancer

Details for clinical trial NCT00798876